Abstract:Adipocytes contribute to metabolic disorders such as obesity, diabetes, and atherosclerosis. Prior characterizations of the transcriptional network driving adipogenesis have overlooked transiently acting transcription factors (TFs), genes, and regulatory elements that are essential for proper differentiation. Moreover, traditional gene regulatory networks provide neither mechanistic details about individual regulatory element–gene relationships nor temporal information needed to define a regulatory hierarchy that prioritizes key regulatory factors. To address these shortcomings, we integrate kinetic chromatin accessibility (ATAC-seq) and nascent transcription (PRO-seq) data to generate temporally resolved networks that describe TF binding events and resultant effects on target gene expression. Our data indicate which TF families cooperate with and antagonize each other to regulate adipogenesis. Compartment modeling of RNA polymerase density quantifies how individual TFs mechanistically contribute to distinct steps in transcription. The glucocorticoid receptor activates transcription by inducing RNA polymerase pause release, whereas SP and AP-1 factors affect RNA polymerase initiation. We identify Twist2 as a previously unappreciated effector of adipocyte differentiation. We find that TWIST2 acts as a negative regulator of 3T3-L1 and primary preadipocyte differentiation. We confirm that Twist2 knockout mice have compromised lipid storage within subcutaneous and brown adipose tissue. Previous phenotyping of Twist2 knockout mice and Setleis syndrome Twist2 – / – patients noted deficiencies in subcutaneous adipose tissue. This network inference framework is a powerful and general approach for interpreting complex biological phenomena and can be applied to a wide range of cellular processes.

Roles of Twist1 in lipid and glucose metabolism

AKT-ions with a TWIST between EMT and MET.

New Roles of Lkb1 in Regulating Adipose Tissue Development and Thermogenesis

Factors Inducing Transdifferentiation Of Myoblasts Into Adipocytes

The Role Of Transcription Factor 7-Like 2 In Metabolic Disorders

Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms

Twist1 downregulation of PGC-1α decreases fatty acid oxidation in tubular epithelial cells, leading to kidney fibrosis

The Role of TWIST1 in Epithelial-Mesenchymal Transition and Cancers

TWIST1 and BMI1 in Cancer Metastasis and Chemoresistance

Kinetic networks identify TWIST2 as a key regulatory node in adipogenesis

Sirtuins: Key players in obesity-associated adipose tissue remodeling

Metabolic Crosstalk: Molecular Links Between Glycogen and Lipid Metabolism in Obesity

The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus

Emerging biological functions of Twist1 in cell differentiation

Sirtuins and Insulin Resistance

The Role of Twist1 in Mutant Huntingtin–induced Transcriptional Alterations and Neurotoxicity

Epithelial mesenchymal transition regulator TWIST1 transcription factor stimulates glucose uptake through upregulation of GLUT1, GLUT3, and GLUT12 in vitro

Roles of protein post-translational modifications in glucose and lipid metabolism: mechanisms and perspectives

Roles of Lysine Methylation in Glucose and Lipid Metabolism: Functions, Regulatory Mechanisms, and Therapeutic Implications

Diverse Roles of SIRT1 in Cancer Biology and Lipid Metabolism

Roles of MicroRNAs in Glucose and Lipid Metabolism in the Heart